WHO ICTRP trial
EVALUATION OF EFFECT OF KETOFOL AND KETODEX IN ELECTROCONVULSIVE THERAPY
CTRI/2021/06/034235 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/06/034235 |
|---|---|
| Public title | EVALUATION OF EFFECT OF KETOFOL AND KETODEX IN ELECTROCONVULSIVE THERAPY |
| Scientific title | EVALUATION OF EFFECT OF KETOFOL AND KETODEX ON DURATION OF SEIZURE ACTIVITY,HEMODYNAMIC PROFILE,RECOVERY TIMES AND CORTICAL ACTIVITY(USING fNIRS) IN PATIENTS UNDERGOING ELECTROCONVULSIVE THERAPY FOR DEPRESSION |
| Primary sponsor | All India Institute of Medical Sciences New Delhi India |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: F32- Major depressive disorder, singleepisode Health Condition 2: F32- Major depressive disorder, singleepisode Health Condition 3: F30-F39- Mood [affective] disorders |
| Interventions | Intervention1: Ketodex drug: ketodex (1-2 mg/kg ketamine and 1µg/kg dexmedetomidine) given as bolus over 5-10 min. This can then be followed by supplemental bolus doses of ketamine (0.5–1 mg/kg) as needed for patients undergoing… |
| Registration date | Jun 14, 2021 |
| Target size | 24 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: